ertapenem sodium

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

InfectionInfection; Diabetic FootSurgical Site InfectionUrinary Tract Infection

Phase 3

A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)

CompletedNCT00379951

Merck Sharp & Dohme LLCUrinary Tract Infection

Start: 2005-06-30End: 2006-05-31Updated: 2017-02-17

Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)

CompletedNCT01254344

Merck Sharp & Dohme LLCInfection, Surgical Site Infection

Start: 2010-12-31End: 2011-12-31Updated: 2017-03-22

Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

CompletedNCT01370616

Merck Sharp & Dohme LLCInfection; Diabetic Foot

Start: 2011-09-02End: 2013-12-18Updated: 2018-08-27

Related Papers

Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.

2016-02-1617 citations

Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study.

2014-08-2310 citations